Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vesifact is a Swiss private drug-delivery technology company that develops and manufactures proprietary formulation systems designed to improve the oral bioavailability of poorly absorbed ingredients. Its core platform, VESIsorb, is a self-emulsifying drug delivery system used across pharmaceuticals, health and wellness products, nutraceuticals, cosmetics, and medical devices. The company highlights work in cannabinoid and terpene formulations, including published human pharmacokinetic data for cannabidiol + beta-caryophyllene and beta-caryophyllene formulations. Vesifact appears to operate primarily as a platform and formulation partner rather than as a traditional therapeutic developer with a broad proprietary clinical pipeline. The company is family-owned and based in Baar, Switzerland.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vesifact.